Administration of perfluorochemicals under hyperbaric oxygen pressure and treatment with free oxygen radical scavengers.
Lutz
J
J
Department of Physiology, University of Wuerzburg, Federal Republic of Germany.
Stark
M
M
D000818:Animals; D001205:Ascorbic Acid / Q000494:pharmacology*; D001802:Blood Substitutes; D004338:Drug Combinations / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D005466:Fluorocarbons / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity*; D005609:Free Radicals; D005978:Glutathione / Q000494:pharmacology*; D006895:Hydroxyethyl Starch Derivatives; D006931:Hyperbaric Oxygenation / Q000009:adverse effects*; D008168:Lung / Q000033:anatomy & histology; D008297:Male; D008775:Methylprednisolone / Q000494:pharmacology*; D009929:Organ Size / Q000187:drug effects; D010100:Oxygen / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D012640:Seizures / Q000209:etiology; D024505:Tocopherols; D014810:Vitamin E / Q000031:analogs & derivatives* / Q000494:pharmacology; D024502:alpha-Tocopherol / Q000031:analogs & derivatives*
D001802:Blood Substitutes; D004338:Drug Combinations; D005466:Fluorocarbons; D005609:Free Radicals; D006895:Hydroxyethyl Starch Derivatives; D014810:Vitamin E; C017323:glucose, glycerol, hydroxyethyl starch, perfluorodecalin, perfluorotripropylamine, pluronic F-68, salts, yolk phospholipids drug combination; D005978:Glutathione; D024502:alpha-Tocopherol; D001205:Ascorbic Acid; D024505:Tocopherols; D010100:Oxygen; D008775:Methylprednisolone